Therapeutically Targeted Anticancer Agents: Inhibitors of Receptor Tyrosine Kinases

E-ISSN： 1875-5607|4|3|273-283

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.4, Iss.3, 2004-03, pp. : 273-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tyrosine Kinase Inhibitors Targeted to the Epidermal Growth Factor Receptor Subfamily: Role as Anticancer Agents

By Noonberg S.B. Benz C.C.

Drugs, Vol. 59, Iss. 4, 2000-04 ,pp. : 753-767

Adis International

Access to resources Recommend Favorite

Receptor Tyrosine Kinases and Anticancer Therapy

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1139-1149

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Receptor Tyrosine Kinases as Targets for Anticancer Therapeutics

Current Medicinal Chemistry, Vol. 12, Iss. 15, 2005-07 ,pp. : 1773-1781

Bentham Science Publishers

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors as anticancer agents

By Supuran Claudiu T Scozzafava Andrea

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite